Beijing Biostar Pharms Co Ltd
Beijing Biostar Pharms Co Ltd 2563.HK Peers
See (2563.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Stock Comparison
2563.HK vs 1093.HK Comparison
2563.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2563.HK stands at 955.74M. In comparison, 1093.HK has a market cap of 63.56B. Regarding current trading prices, 2563.HK is priced at $4.41, while 1093.HK trades at $5.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2563.HK currently has a P/E ratio of -9.19, whereas 1093.HK's P/E ratio is 13.83. In terms of profitability, 2563.HK's ROE is N/A, compared to 1093.HK's ROE of +0.17%. Regarding short-term risk, 2563.HK is more volatile compared to 1093.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2563.HK.